Both biomarkers were also evaluated to predict high-risk PCa, being the respective AUCs of 0.707 (for the PCPT risk calculator), 0.752 (plus TMPRSS2:ERG) and 0.779 (plus TMPRSS2:ERG and PCA3). This evidence concerns the gene ERG and posterior cortical atrophy.